198 related articles for article (PubMed ID: 37330108)
1. GM1 oligosaccharide efficacy against α-synuclein aggregation and toxicity in vitro.
Fazzari M; Di Biase E; Zaccagnini L; Henriques A; Callizot N; Ciampa MG; Mauri L; Carsana EV; Loberto N; Aureli M; Mari L; Civera M; Vasile F; Sonnino S; Bartels T; Chiricozzi E; Lunghi G
Biochim Biophys Acta Mol Cell Biol Lipids; 2023 Sep; 1868(9):159350. PubMed ID: 37330108
[TBL] [Abstract][Full Text] [Related]
2. GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson's Disease.
Schneider JS; Aras R; Williams CK; Koprich JB; Brotchie JM; Singh V
Sci Rep; 2019 Jun; 9(1):8362. PubMed ID: 31182727
[TBL] [Abstract][Full Text] [Related]
3. GM1 ganglioside modifies microglial and neuroinflammatory responses to α-synuclein in the rat AAV-A53T α-synuclein model of Parkinson's disease.
Schneider JS; Singh G; Williams CK; Singh V
Mol Cell Neurosci; 2022 May; 120():103729. PubMed ID: 35447351
[TBL] [Abstract][Full Text] [Related]
4. Alpha-Synuclein and GM1 Ganglioside Co-Localize in Neuronal Cytosol Leading to Inverse Interaction-Relevance to Parkinson's Disease.
Kumar R; Chowdhury S; Ledeen R
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542297
[TBL] [Abstract][Full Text] [Related]
5. Parkinson's disease recovery by GM1 oligosaccharide treatment in the B4galnt1
Chiricozzi E; Mauri L; Lunghi G; Di Biase E; Fazzari M; Maggioni M; Valsecchi M; Prioni S; Loberto N; Pomè DY; Ciampa MG; Fato P; Verlengia G; Cattaneo S; Assini R; Wu G; Alselehdar S; Ledeen RW; Sonnino S
Sci Rep; 2019 Dec; 9(1):19330. PubMed ID: 31852959
[TBL] [Abstract][Full Text] [Related]
6. GM1 specifically interacts with alpha-synuclein and inhibits fibrillation.
Martinez Z; Zhu M; Han S; Fink AL
Biochemistry; 2007 Feb; 46(7):1868-77. PubMed ID: 17253773
[TBL] [Abstract][Full Text] [Related]
7. GM1 Oligosaccharide Efficacy in Parkinson's Disease: Protection against MPTP.
Fazzari M; Lunghi G; Henriques A; Callizot N; Ciampa MG; Mauri L; Prioni S; Carsana EV; Loberto N; Aureli M; Mari L; Sonnino S; Chiricozzi E; Di Biase E
Biomedicines; 2023 Apr; 11(5):. PubMed ID: 37238977
[TBL] [Abstract][Full Text] [Related]
8. Intranasal infusion of GD3 and GM1 gangliosides downregulates alpha-synuclein and controls tyrosine hydroxylase gene in a PD model mouse.
Itokazu Y; Fuchigami T; Morgan JC; Yu RK
Mol Ther; 2021 Oct; 29(10):3059-3071. PubMed ID: 34111562
[TBL] [Abstract][Full Text] [Related]
9. Altered ion channel formation by the Parkinson's-disease-linked E46K mutant of alpha-synuclein is corrected by GM3 but not by GM1 gangliosides.
Di Pasquale E; Fantini J; Chahinian H; Maresca M; Taïeb N; Yahi N
J Mol Biol; 2010 Mar; 397(1):202-18. PubMed ID: 20114052
[TBL] [Abstract][Full Text] [Related]
10. The relationship between depletion of brain GM1 ganglioside and Parkinson's disease.
Sonnino S
FEBS Open Bio; 2023 Sep; 13(9):1548-1557. PubMed ID: 36638010
[TBL] [Abstract][Full Text] [Related]
11. N-alpha-acetylation of α-synuclein increases its helical folding propensity, GM1 binding specificity and resistance to aggregation.
Bartels T; Kim NC; Luth ES; Selkoe DJ
PLoS One; 2014; 9(7):e103727. PubMed ID: 25075858
[TBL] [Abstract][Full Text] [Related]
12. GM1 Ganglioside role in the interaction of Alpha-synuclein with lipid membranes: Morphology and structure.
Perissinotto F; Rondelli V; Parisse P; Tormena N; Zunino A; Almásy L; Merkel DG; Bottyán L; Sajti S; Casalis L
Biophys Chem; 2019 Dec; 255():106272. PubMed ID: 31698188
[TBL] [Abstract][Full Text] [Related]
13. Gangliosides, α-Synuclein, and Parkinson's Disease.
Ledeen RW; Wu G
Prog Mol Biol Transl Sci; 2018; 156():435-454. PubMed ID: 29747823
[TBL] [Abstract][Full Text] [Related]
14. Turning the spotlight on the oligosaccharide chain of GM1 ganglioside.
Chiricozzi E; Di Biase E; Lunghi G; Fazzari M; Loberto N; Aureli M; Mauri L; Sonnino S
Glycoconj J; 2021 Feb; 38(1):101-117. PubMed ID: 33620588
[TBL] [Abstract][Full Text] [Related]
15. Role of the GM1 ganglioside oligosaccharide portion in the TrkA-dependent neurite sprouting in neuroblastoma cells.
Chiricozzi E; Pomè DY; Maggioni M; Di Biase E; Parravicini C; Palazzolo L; Loberto N; Eberini I; Sonnino S
J Neurochem; 2017 Dec; 143(6):645-659. PubMed ID: 28796418
[TBL] [Abstract][Full Text] [Related]
16. GM1 ganglioside exerts protective effects against glutamate-excitotoxicity via its oligosaccharide in wild-type and amyotrophic lateral sclerosis motor neurons.
Lunghi G; Di Biase E; Carsana EV; Henriques A; Callizot N; Mauri L; Ciampa MG; Mari L; Loberto N; Aureli M; Sonnino S; Spedding M; Chiricozzi E; Fazzari M
FEBS Open Bio; 2023 Dec; 13(12):2324-2341. PubMed ID: 37885330
[TBL] [Abstract][Full Text] [Related]
17. Structural Features and Toxicity of α-Synuclein Oligomers Grown in the Presence of DOPAC.
Palazzi L; Fongaro B; Leri M; Acquasaliente L; Stefani M; Bucciantini M; Polverino de Laureto P
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34199427
[TBL] [Abstract][Full Text] [Related]
18. Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons.
Pujols J; Peña-Díaz S; Lázaro DF; Peccati F; Pinheiro F; González D; Carija A; Navarro S; Conde-Giménez M; García J; Guardiola S; Giralt E; Salvatella X; Sancho J; Sodupe M; Outeiro TF; Dalfó E; Ventura S
Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10481-10486. PubMed ID: 30249646
[TBL] [Abstract][Full Text] [Related]
19. (De)stabilization of Alpha-Synuclein Fibrillary Aggregation by Charged and Uncharged Surfactants.
Loureiro JA; Andrade S; Goderis L; Gomez-Gutierrez R; Soto C; Morales R; Pereira MC
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830391
[TBL] [Abstract][Full Text] [Related]
20. Restoration of Adult Neurogenesis by Intranasal Administration of Gangliosides GD3 and GM1 in The Olfactory Bulb of A53T Alpha-Synuclein-Expressing Parkinson's-Disease Model Mice.
Fuchigami T; Itokazu Y; Morgan JC; Yu RK
Mol Neurobiol; 2023 Jun; 60(6):3329-3344. PubMed ID: 36849668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
